Close this search box.

Press release: Reaching big heights at Pivot Park

Grizzly, the newest building at Pivot Park, has reached it’s highest point this week. Grizzly provides space for offices and laboratories. This space is much needed, because successful start-ups and scale-ups are outgrowing their space. With the arrival of Grizzly, Pivot Park stimulates innovation and employment. Companies will have the space and facilities to develop further. This allows them to excel further and to continue to play a leading role worldwide in the field in which they operate. 

Growth by success
“Over the past five years, the number of leased square meters has doubled,” said Brigitte Drees, CEO Pivot Park. “Companies already located at our park are developing and currently outgrowing their premises. Not only companies of the first hour, but also the younger companies are successful. They frequently manage to turn innovations into a drug on its way to market introduction. So, since the existing buildings are full, we are now building new, modern sustainable buildings for these companies.”

Grizzly is a gas-free and ‘Bijna Energie Neutraal Gebouw’ (BENG) through for example the use of fossil-free systems, LED lighting and solar panels. Traditionally, chemical companies use gas for their research and production processes. Through the use of induction, for example, the lab also manages to carry out work without gas. The completion is set to be done at the end of 2023 by Dura Vermeer. After that, the tenants of Grizzly will start furnishing their own spaces. 

Joint financing makes realization possible
Shareholders the province of North Brabant and the municipality of Oss are financing the building and thus contributing to profitable operation. According to deputy Erik Ronnes, this is about much more than erecting a brick building. “With this new building, we strengthen the ecosystem that exists on such a campus. It is important that companies and people sit near each other, share facilities and thus come to new products and services. In this way, a campus is the core of entrepreneurship, innovation and education.”

Grizzly is located at the biopharmaceutical campus Pivot Park, which currently provides space for more than 1.000 employees. With its 60 companies, the company plays an important role as an employer in the region. Brigitte Drees: “That 1.000 employees is an important milestone. Developments are going fast now. New construction is important to continue this growth. In this way, Pivot Park facilitates that these companies are retained for Oss and remain in Oss for the next 10 years.

Pivot Park
From starting entrepreneurs funded in part by the Brabantse Ontwikkelings Maatschappij (BOM), fast-growing scale-ups to mature market leaders, Pivot Park helps these innovative companies take the next steps. In addition, the many companies on the park can help each other in the complex process of drug development. Tailored facilities, shared sources of knowledge, short lines to specialist financiers and also flexible access to outstanding scientific and entrepreneurial expertise also make Pivot Park the hotspot for pharmaceutical innovation in Europe.

*Photo was taken by photographer Marcel van der Burg.  

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?


The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.